Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GALT | Stock Option (right to buy) | Award | $0 | +40K | $0.00 | 40K | Jan 24, 2022 | Common Stock | 40K | $1.98 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan. |
F2 | The options vest 100% on December 31, 2022. |